| Disease | AND TOLERANCE WAS EXCELLENT. TREATMENT WITH PHYTO SOYA RESULTED IN A SIGNIFICANT IMPROVEMENT OF THE SYMPTOMATOLOGY THAT ACCOMPANIES THE LACK OF ESTROGEN DURING MENOPAUSE.
5,48% PATIENTS DID NOT IMPROVE WITH THE TREATMENT. THE AVERAGE REDUCTION WAS 47.8%, WHICH IS EQUIVALENT TO 4 HOT FLUSHES. ALL THE OTHER STUDIED PARAMETERS ALSO SHOWED A STATISTICALLY SIGNIFICANT DECREASE. NO SEVERE SIDE-EFFECTS WERE REPORTED
OF LIBIDO AND BONE PAIN. EACH PATIENT RECEIVED 35 MG ISOFLAVONES PER DAY IN TWO DOSES. DURING THE FOUR MONTHS' TREATMENT, A STATISTICALLY SIGNIFICANT DECREASE IN THE NUMBER OF HOT FLUSHES WITH PHYTO SOYA WAS EXPERIENCED BY 80.82% WOMEN; ONLY
MAIN OBJECT OF THE PRESENT STUDY WAS TO INVESTIGATE ITS EFFICACY IN ALLEVIATING THE SYMPTOMATOLOGY DERIVED FROM THE LACK OF ESTROGEN, MAINLY HOT FLUSHES, BUT ALSO OTHER SYMPTOMS SUCH AS SLEEP DISORDER, ANXIETY, DEPRESSION, VAGINAL DRYNESS, LOSS
A MULTICENTRIC, OPEN, PROSPECTIVE, OBSERVATIONAL AND NON-RANDOMIZED CLINICAL TRIAL WAS CARRIED OUT IN SPAIN WITH 190 POSTMENOPAUSAL WOMEN RECEIVING A SOY PREPARATION RICH IN ISOFLAVONES (PHYTOSAYA1, CAPSULES CONTAINING 17.5 MG ISOFLAVONES). THE |